RBC Capital Downgrades Pharmacyclics (PCYC) to Sector Perform
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Rating Summary:
5 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 1 | New: 7
Rating Summary:
5 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 1 | New: 7
Join SI Premium – FREE
RBC Capital downgraded Pharmacyclics (NASDAQ: PCYC) from Outperform to Sector Perform.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $14.62 yesterday.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $14.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Atlas Arteria Ltd. (ALX:AU) (MAQAF) to Underperform
- Canaccord Downgrades Mayne Pharma Group Ltd. (MYX:AU) (MAYNF) to Spec. Buy
- JPMorgan Reinstates Puma SE (PUM:GR) (PMMAF) at Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
